Want to see AU:PNV full AI Analyst Report?

Polynovo (PNV) Price & Analysis

102 Followers

PNV Stock Chart & Stats

AU$1.01

AU$0.01(0.49%)

At close: Jan 09 4:00 PM EST

AU$1.01

AU$0.01(0.49%)

Day’s Range― - ―

52-Week RangeAU$0.87 - AU$1.67

Previous CloseN/A

Volume733.50K

Average Volume (3M)1.48M

Market Cap

AU$704.66M

Enterprise ValueAU$703.73M

Total Cash (Recent Filing)AU$29.26M

Total Debt (Recent Filing)AU$31.74M

Price to Earnings (P/E)72.4

Beta1.78

Next Earnings

Aug 21, 2026

EPS Estimate

0.01

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.01

Shares Outstanding690,843,000

10 Day Avg. Volume1,478,953

30 Day Avg. Volume1,476,427

Financial Highlights & Ratios

PEG Ratio0.42

Price to Book (P/B)9.95

Price to Sales (P/S)6.51

P/FCF Ratio-76.87

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

AU$1.56

Price Target Upside54.46% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)0.02

Revenue Forecast (FY)AU$183.09M

Bulls Say, Bears Say

Bulls Say

U.S. Commercial Scale & Account ExpansionRapid U.S. account growth and a >80‑rep commercial team indicate durable sales muscle in the largest market. Broader hospital penetration reduces single‑account risk, supports recurring procedure volumes and predictable consumable demand, underpinning medium‑term revenue resilience.

Very High Gross Margins & Improving EBITDAExceptionally high gross margins reflect a differentiated, low variable‑cost polymer platform and pricing power. Improving adjusted EBITDA shows operating leverage. Together these support reinvestment in clinical trials and commercialization while providing margin headroom against pricing or reimbursement pressure.

Scaled Manufacturing Capacity (Port Melbourne)A ~5x capacity increase materially reduces supply constraints and enables multi‑SKU production for outpatient and international rollouts. Greater scale should lower per‑unit fixed costs, improve gross margins sustainably, and support faster uptake without bottleneck risk as demand grows.

Bears Say

Weak Cash‑flow ConversionPersistently weak free cash flow and poor conversion of earnings to cash limit the company’s ability to self‑fund expansion, clinical trials and working capital. This increases dependence on external financing and raises execution risk if cash generation does not improve in coming quarters.

Outpatient Reimbursement Uncertainty (CMS)Ambiguous outpatient reimbursement creates a structural barrier to monetizing the large office‑based opportunity. A required RCT adds time, cost and execution risk; until CMS clarity is achieved, outpatient revenue remains upside rather than a dependable growth driver for the medium term.

Lumpy Burn Market & Limited GuidanceCore burn market variability and seasonality make volumes and revenue lumpy, complicating capacity planning and cash forecasting. Management’s decision to withhold formal guidance reflects structural predictability limits that can impede long‑term resource allocation and investor visibility.

Polynovo News

JPMorgan ceases substantial holding in Polynovo

The latest update is out from Polynovo ( ($AU:PNV) ). JPMorgan Chase & Co. and its affiliates have...

22d ago

State Street group exits substantial holder position in Polynovo

An announcement from Polynovo ( ($AU:PNV) ) is now available. State Street Corporation and several of its asset...

1M ago

PolyNovo Strengthens U.S. Burn Trial PMA Bid, Pushes Filing to Late 2026

The latest announcement is out from Polynovo ( ($AU:PNV) ). PolyNovo has finalised the Clinical Study Report for...

2M ago

PolyNovo tightens share trading rules as global wound-care business expands

Polynovo ( ($AU:PNV) ) has shared an announcement. PolyNovo has updated its Share Trading Policy to align with...

3M ago

PolyNovo names CSL veteran Marthe D’Ombrain as Chief Scientific Officer to drive next-phase growth

An update from Polynovo ( ($AU:PNV) ) is now available. PolyNovo has appointed Dr Marthe D’Ombrain as Chief...

3M ago

PolyNovo Appoints New Director With No Current Securities Interests

Polynovo ( ($AU:PNV) ) has issued an announcement. PolyNovo Limited has announced the appointment of Charmaine Hilary Gittleson...

4M ago

PolyNovo strengthens board with appointment of Dr Charmaine Gittleson

Polynovo ( ($AU:PNV) ) has provided an update. PolyNovo has appointed former CSL chief medical officer Dr Charmaine...

4M ago

PolyNovo Director Robert Douglas Acquires Initial Stake of 151,000 Shares

The latest announcement is out from Polynovo ( ($AU:PNV) ). PolyNovo Limited has disclosed a change in director...

4M ago

PolyNovo Director Andrew Lumsden Doubles Indirect Shareholding

Polynovo ( ($AU:PNV) ) has issued an announcement. PolyNovo has disclosed a change in director Andrew Lumsden’s indirect...

5M ago

PolyNovo Director Leon Hoare Increases Indirect Shareholding via On-Market Purchase

The latest announcement is out from Polynovo ( ($AU:PNV) ). PolyNovo Limited has reported a change in the...

5M ago

PNV FAQ

What was Polynovo Limited’s price range in the past 12 months?

Polynovo Limited lowest share price was AU$0.86 and its highest was AU$1.67 in the past 12 months.

What is Polynovo Limited’s market cap?

Polynovo Limited’s market cap is AU$704.66M.

When is Polynovo Limited’s upcoming earnings report date?

Polynovo Limited’s upcoming earnings report date is Aug 21, 2026 which is in 36 days.

How were Polynovo Limited’s earnings last quarter?

Polynovo Limited released its earnings results on Feb 20, 2026. The company reported AU$0 earnings per share for the quarter, missing the consensus estimate of AU$0.006 by -AU$0.006.

Is Polynovo Limited overvalued?

According to Wall Street analysts Polynovo Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Polynovo Limited pay dividends?

Polynovo Limited does not currently pay dividends.

What is Polynovo Limited’s EPS estimate?

Polynovo Limited’s EPS estimate is 0.01.

How many shares outstanding does Polynovo Limited have?

Polynovo Limited has 690,843,000 shares outstanding.

What happened to Polynovo Limited’s price movement after its last earnings report?

Polynovo Limited reported an EPS of AU$0 in its last earnings report, missing expectations of AU$0.006. Following the earnings report the stock price went down -8.458%.

Which hedge fund is a major shareholder of Polynovo Limited?

Currently, no hedge funds are holding shares in AU:PNV

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Polynovo Stock Smart Score

Neutral

Fundamentals

Return on Equity

11.87%

Trailing 12-Months

Asset Growth

17.90%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Polynovo Limited

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Polynovo (PNV) Earnings & Revenues

Historic Earnings Reports

PNV Stock 12 Month Forecast

Average Price Target

AU$1.56

▲(54.46% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"AU$2","-1":"-AU$1","-0.25":"-AU$0.25","0.5":"AU$0.5","1.25":"AU$1.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.56,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$1.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.56,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$1.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.56,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$1.56</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.25,0.5,1.25,2],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.935,0.9830769230769232,1.0311538461538463,1.0792307692307692,1.1273076923076923,1.1753846153846155,1.2234615384615386,1.2715384615384617,1.3196153846153846,1.3676923076923078,1.415769230769231,1.4638461538461538,1.5119230769230771,{"y":1.56,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.935,0.9830769230769232,1.0311538461538463,1.0792307692307692,1.1273076923076923,1.1753846153846155,1.2234615384615386,1.2715384615384617,1.3196153846153846,1.3676923076923078,1.415769230769231,1.4638461538461538,1.5119230769230771,{"y":1.56,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.935,0.9830769230769232,1.0311538461538463,1.0792307692307692,1.1273076923076923,1.1753846153846155,1.2234615384615386,1.2715384615384617,1.3196153846153846,1.3676923076923078,1.415769230769231,1.4638461538461538,1.5119230769230771,{"y":1.56,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.2,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.235,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.315,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.405,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.32,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.185,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.25,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.99,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.935,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.995,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.165,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.935,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >